HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Pekka Kuukasjärvi Matti Tarkka Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sioris, T. Articles by Tarkka, M. Search for Related Content PubMed PubMed Citation Articles by Sioris, T. Articles by Tarkka, M. Related Collections Lung - cancer

Eur J Cardiothorac Surg 2003;23:403-408
© 2003 Elsevier Science NL

Comparison of computed tomography and systematic lymph node dissection in determining TNM and stage in non-small cell lung cancer

^a Department of Cardiothoracic surgery, Tampere University Hospital, Tampere, Finland
^b Department of Radiology, Tampere University Hospital, Tampere, Finland
^c Department of Pathology, Tampere University Hospital, Tampere, Finland
^d Department of Pulmonary Medicine, Tampere University Hospital, Tampere, Finland

Received 6 May 2002; received in revised form 26 November 2002; accepted 2 December 2002.

^* Corresponding author. Kaustakuja 6A, 00950 Helsinki, Finland
e-mail: sioris{at}saunalahti.fi

Objective: To compare computed tomography (CT)-based clinical TNM and staging to surgical-pathological staging with systematic lymph node dissection in primary non-small cell lung cancer. Methods: The study included 49 non-small cell lung cancer patients that underwent lung resection and systematic lymph node dissection between 1997 and 2001. Preoperative clinical and CT findings were compared with surgical-pathological findings. Lymph nodes with a shortest diameter of over 1 cm on CT were considered abnormal, but did not contraindicate surgery. Patients with CT indicating an invasive T4 tumor, pleural carcinosis, or bulky N2 disease were excluded. Results: Sixty-five percent (32/49) had epidermoid carcinoma, and 25% (12/49) had adenocarcinoma. N2 metastases were found in 12% (6/49). The clinical T category was correct in 71% (35/49), and the N category in 55% (27/49). The sensitivity for detecting N2 disease was 67% (4/6), and the spesificity was 81% (35/43). The positive predictive value for N2 disease was 33% (4/12), and the negative predictive value was 95% (35/37). Node-by-node agreement on N2 metastatic location was 17% (1/6). Skip N2 metastases without any N1 involvement were found in 4% (2/49), or 33% (2/6) of all N2 cases. The clinical stage was correct in 45% (22/49), and complete TNM agreement was 37% (18/49). Conclusions: The clinical TNM and staging based on CT are inaccurate. The sensitivity for detecting N2 disease is poor, especially on node-by node basis. Preoperative exclusion of N2 metastases is quite reliable, but a positive finding should always be verified. Systematic mediastinal lymph node dissection is necessary to detect N2 metastases inaccessible to cervical mediastinoscopy, and skip N2 metastases without N1 involvement.

Key Words: Non-small cell lung cancer • Computed tomography • Staging • Operability • Systematic lymph node dissection • Skip metastasis

This article has been cited by other articles:

				M. Tamura, M. Oda, Y. Tsunezuka, I. Matsumoto, K. Kawakami, Y. Ohta, and G. Watanabe Chest CT and Serum Vascular Endothelial Growth Factor-C Level To Diagnose Lymph Node Metastasis in Patients With Primary Non-small Cell Lung Cancer Chest, August 1, 2004; 126(2): 342 - 346. [Abstract] [Full Text] [PDF]